Non-surgical Periodontal Treatment and Periostin Levels
The Effect of Non-surgical Periodontal Treatment on Serum and Gingival Crevicular Fluid Periostin Levels
1 other identifier
interventional
48
1 country
1
Brief Summary
Two different studies were planned from the recruited samples. The aim of these studies was to investigate the effect of non-surgical periodontal treatment on the inflammatory markers levels in serum and gingival crevicular fluid (GCF) in patients with periodontitis. There were two groups consisting of individuals who had periodontitis and those who were healthy, with 24 individuals in each group. Periostin levels were assessed at baseline, at the 24th h, 48th h, 14th day 1st month, 3rd month after non-surgical periodontal treatment in serum and GCF samples by the Elisa method in the first study. In parallel, interleukin 1 (IL)-beta and fibroblast growth factor levels were measured. Progranulin levels were assessed at baseline, at the 24th h, 48th h, 14th day 1st month, 3rd month after non-surgical periodontal treatment in serum and GCF samples by the Luminex method in the second study. In parallel, vascular endothelial growth factor, IL-1 beta, tumor necrosis factor-alpha, and IL-10 levels were measured.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2021
CompletedFirst Submitted
Initial submission to the registry
September 6, 2022
CompletedFirst Posted
Study publicly available on registry
September 10, 2022
CompletedOctober 11, 2023
October 1, 2023
1.7 years
September 6, 2022
October 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of Periostin levels in non-surgical periodontal treatment
The effect of non-surgical periodontal treatment on serum and gingival crevicular fluid periostin levels
0-3 month
Secondary Outcomes (1)
Evaluation of IL-1B and FGF levels in non-surgical periodontal treatment
0-3 month
Study Arms (2)
Periodontally healthy group
NO INTERVENTION24 participants were included in this group.
Periodontitis group
ACTIVE COMPARATOR24 participants were included in this group.
Interventions
Full month non-surgical periodontal treatment procedure was applied to the periodontitis group.
Eligibility Criteria
You may qualify if:
- individuals who had never smoked;
- individuals who had no history of periodontal treatment in the past 6 months;
- individuals who had had no antibiotic therapy in the past 3 months;
- individuals who had more than 18 teeth.
You may not qualify if:
- individuals who were pregnant;
- individuals were current or former smokers;
- individuals who had any self-reported systemic condition or disease, which are confounding factors e.g. AIDS, rheumatoid arthritis, cardiovascular diseases, diabetes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mustafa Kemal University
Hatay, 31000, Turkey (Türkiye)
Related Publications (17)
Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J. 1975 Dec;25(4):229-35.
PMID: 1058834RESULTCaton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, Kornman KS, Mealey BL, Papapanou PN, Sanz M, Tonetti MS. A new classification scheme for periodontal and peri-implant diseases and conditions - Introduction and key changes from the 1999 classification. J Periodontol. 2018 Jun;89 Suppl 1:S1-S8. doi: 10.1002/JPER.18-0157.
PMID: 29926946RESULTChapple IL, Landini G, Griffiths GS, Patel NC, Ward RS. Calibration of the Periotron 8000 and 6000 by polynomial regression. J Periodontal Res. 1999 Feb;34(2):79-86. doi: 10.1111/j.1600-0765.1999.tb02226.x.
PMID: 10207836RESULTChapple IL, Mason GI, Garner I, Matthews JB, Thorpe GH, Maxwell SR, Whitehead TP. Enhanced chemiluminescent assay for measuring the total antioxidant capacity of serum, saliva and crevicular fluid. Ann Clin Biochem. 1997 Jul;34 ( Pt 4):412-21. doi: 10.1177/000456329703400413.
PMID: 9247675RESULTLOE H, SILNESS J. PERIODONTAL DISEASE IN PREGNANCY. I. PREVALENCE AND SEVERITY. Acta Odontol Scand. 1963 Dec;21:533-51. doi: 10.3109/00016356309011240. No abstract available.
PMID: 14121956RESULTQuirynen M, Bollen CM, Vandekerckhove BN, Dekeyser C, Papaioannou W, Eyssen H. Full- vs. partial-mouth disinfection in the treatment of periodontal infections: short-term clinical and microbiological observations. J Dent Res. 1995 Aug;74(8):1459-67. doi: 10.1177/00220345950740080501.
PMID: 7560400RESULTRudin HJ, Overdiek HF, Rateitschak KH. Correlation between sulcus fluid rate and clinical and histological inflammation of the marginal gingiva. Helv Odontol Acta. 1970 Apr;14(1):21-6. No abstract available.
PMID: 5438796RESULTSchulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010 Jun 1;152(11):726-32. doi: 10.7326/0003-4819-152-11-201006010-00232. Epub 2010 Mar 24.
PMID: 20335313RESULTSILNESS J, LOE H. PERIODONTAL DISEASE IN PREGNANCY. II. CORRELATION BETWEEN ORAL HYGIENE AND PERIODONTAL CONDTION. Acta Odontol Scand. 1964 Feb;22:121-35. doi: 10.3109/00016356408993968. No abstract available.
PMID: 14158464RESULTTonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Clin Periodontol. 2018 Jun;45 Suppl 20:S149-S161. doi: 10.1111/jcpe.12945.
PMID: 29926495RESULTTonetti MS, Sanz M. Implementation of the new classification of periodontal diseases: Decision-making algorithms for clinical practice and education. J Clin Periodontol. 2019 Apr;46(4):398-405. doi: 10.1111/jcpe.13104.
PMID: 30883878RESULTYang N, Li Y, Wang G, Ding Y, Jin Y, Xu Y. Tumor necrosis factor-alpha suppresses adipogenic and osteogenic differentiation of human periodontal ligament stem cell by inhibiting miR-21/Spry1 functional axis. Differentiation. 2017 Sep-Oct;97:33-43. doi: 10.1016/j.diff.2017.08.004. Epub 2017 Sep 1.
PMID: 28946056RESULTDaniel R, He Z, Carmichael KP, Halper J, Bateman A. Cellular localization of gene expression for progranulin. J Histochem Cytochem. 2000 Jul;48(7):999-1009. doi: 10.1177/002215540004800713.
PMID: 10858277RESULTLi X, Zuo Z, Chen Q, Li J, Tang W, Yang P. Progranulin is highly expressed in patients with chronic periodontitis and protects against experimental periodontitis in rats. J Periodontol. 2018 Dec;89(12):1418-1427. doi: 10.1002/JPER.18-0132. Epub 2018 Sep 11.
PMID: 29999528RESULTHoriuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF, Kudo A. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res. 1999 Jul;14(7):1239-49. doi: 10.1359/jbmr.1999.14.7.1239.
PMID: 10404027RESULTMatsuzawa M, Arai C, Nomura Y, Murata T, Yamakoshi Y, Oida S, Hanada N, Nakamura Y. Periostin of human periodontal ligament fibroblasts promotes migration of human mesenchymal stem cell through the alphavbeta3 integrin/FAK/PI3K/Akt pathway. J Periodontal Res. 2015 Dec;50(6):855-63. doi: 10.1111/jre.12277. Epub 2015 Apr 20.
PMID: 25900259RESULTSari A, Santamaria P, Nibali L. The effect of non-surgical periodontal treatment on progranulin levels. J Periodontol. 2025 Aug 25. doi: 10.1002/jper.11396. Online ahead of print.
PMID: 40853679DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aysegul Sari, PhD
Hatay Mustafa Kemal University Dental Faculty
- STUDY CHAIR
Oguzhan Ozcan, Prof
Hatay Mustafa Kemal University Medical Faculty
- STUDY DIRECTOR
Alpdogan Kantarci, Prof
Boston University Goldman School of Dental Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Scientific research projects
Study Record Dates
First Submitted
September 6, 2022
First Posted
September 10, 2022
Study Start
December 1, 2019
Primary Completion
August 1, 2021
Study Completion
November 1, 2021
Last Updated
October 11, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share